Last edition
News about Market
Thermo Fisher and NVIDIA Partner to Advance AI-Driven Scientific Instrumentation
Under the partnership, Thermo Fisher Scientific and NVIDIA will connect laboratory instruments and data systems with advanced AI capabilities to streamline operations and accelerate scientific research.
Market | 14/01/2026 | By News Bureau | 220
EQT Life Sciences Exits Vivasure Medical Following Sale to Haemonetics
EQT Life Sciences, formerly known as LSP, one of Europe’s largest life sciences investors, has announced that its LSP Health Economics Fund has exited Vivasure Medical Limited, a Galway-based medical device company, following its acquisition by Haemonetics Corporation, a global medical technology company.
Market | 13/01/2026 | By Darshana | 304
West Pharmaceutical Services has entered a definitive agreement to divest the manufacturing and supply rights of its SmartDose 3.5mL On-Body Delivery System to AbbVie, as part of a strategic portfolio review, with the transaction expected to close in mid-2026.
Market | 13/01/2026 | By News Bureau | 474
Merck Explores USD 28-32 Billion Buyout of Oncology Biotech Revolution Medicines
Merck & Co. is in discussions to acquire U.S.-based oncology biotech Revolution Medicines in a deal that could value the company between USD 28 billion and USD 32 billion, according to people familiar with the matter.
Market | 11/01/2026 | By Darshana | 355
MediLink, Roche Sign Global Licensing Deal for YL201 ADC Therapy
Agreement includes USD 570 million upfront and milestones to advance B7H3-targeting solid tumor cancer treatment worldwide.
Market | 09/01/2026 | By News Bureau | 586
ABS Bio Buys Cureline, Enhancing Biospecimen Access and Execution
The add-on acquisition of Cureline by ABS Bio, a 3 Boomerang portfolio company, expands ABS Bio’s capabilities, geographic reach and client base while strengthening its end-to-end biospecimen services.
Market | 08/01/2026 | By News Bureau | 252
Dr Reddy's Launches Recombinant Hepatitis E Vaccine Hevaxin in India
According to Dr Reddy’s, clinical studies show that Hevaxin offers protective efficacy, durable immunity, and a favourable immune response, supported by an established safety and tolerability profile.
Market | 07/01/2026 | By News Bureau | 242
Esco Aster Signs cGMP Exosome Manufacturing Deal with Shine-On Biomedical
Esco Aster has entered into a clinical cGMP manufacturing agreement with Shine-On Biomedical to support the production of a first-in-class HLA-G–targeting exosome drug delivery platform, while also providing technical services for exploratory exosome loading feasibility studies to advance the programme’s development.
Market | 07/01/2026 | By News Bureau | 205
Novo Nordisk Introduces Wegovy Pill with knownwell as NovoCare Provider
Novo Nordisk has launched Wegovy in an oral pill form, marking the first FDA-approved oral GLP-1 therapy, with knownwell recognised as a NovoCare provider to support broader patient access to clinician-led metabolic care across the US.
Market | 06/01/2026 | By News Bureau | 259
Generic Drug Maker Hindustan Laboratories Files IPO Papers With SEBI
Hindustan Laboratories, an Indian manufacturer of generic pharmaceutical formulations, has filed draft papers with the Securities and Exchange Board of India (SEBI) to launch an initial public offering (IPO).
Market | 06/01/2026 | By Darshana | 177
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy